The market research report, entitled Drug Discovery Informatics Market shows good possibilities in the Drug Discovery Informatics Market during the next five-year period and ensures more information regarding market trends. The following summary will give an overview of the drivers, challenges and key players in the market.
Global Drug Discovery Informatics Market Forecast:
Drug Discovery Informatics market is likely to witness an impressive CAGR of 9.3% during the forecast period. The prime factors that are likely to drive the market are the increasing expenditure in RD activities, growing support for research in the pharmaceutical areas, especially for rare diseases, and the escalating use of informatics for discovery of new drugs.
Key Players
The following are some of the key players in the Drug Discovery Informatics Market:
- Accenture PLC
- Albany Molecular Research Inc.
- Charles River Laboratories International, Inc.
- Clarivate Analytics LLC
- Eurofins Scientific SE
- IBM Corporation
- Jubilant Life Sciences Limited
- PerkinElmer Inc.
- Schrödinger, Inc.
- Thermo Fisher Scientific Inc.
COVID-19 Impact on Global Drug Discovery Informatics Market
The COVID-19 pandemic is likely to favourably impact market growth. To curb the spread of the virus, countries worldwide are imposing restrictions and are promoting social distancing measures. Strict restrictions on the movement of people are further expected to negatively impact land-based casino operations.
Drug Discovery Informatics Market Segmentation:
The report segments based upon demographics, geographics, benefits and volume etc, has different driving factors and identifies the most-attractive segments and sub-segments. Drug Discovery Informatics Market segmentation will not only help marketers to be more efficient in terms of time, money and other resources but also allows companies to learn about their target audience so that they can tailor campaigns and increase market share and revenue.
Based on the function type, the market is segmented as sequencing target data analysis, docking, molecular modelling, library database preparation, and others. The sequencing target data analysis segment held the largest share of the market in 2019, owing to the increased application of sequencing analysis and ease of handling information from different sources and domains. The segment is likely to maintain its leading position during the forecast period as well.
Based on the end-user type, the drug discovery informatics market is segmented as pharmaceutical companies, biotechnology companies, contract research organizations (CROs), and others. The pharmaceutical companies’ segment led the market in 2019, and is expected to dominate the market over the forecast period. The growth of the segment is driven by the extensive use of software for pre-clinical research developmental activities, target identification, compound screening and lead identification, and streamlining drug discovery processes.
Request a sample- https://www.stratviewresearch.com/Request-Sample/940/drug-discovery-informatics-market.html#form
About Stratview Research
Stratview Research is a global market intelligence firm helping its clients’ tract the ever-evolving market scenarios through customised and syndicated reports. The reports offered here are gathered with the help of our wide-ranging and reliable secondary sources and in-depth interviews with the linchpins within the market. Extrapolated through primary and secondary research, Stratview Research’s reports help you remain ahead of the curve by enabling you to understand the current market trends and challenges coming on your way. Our strong team of industry veterans and researchers assure high quality research and strategic insights that help companies worldwide in effective decision making.
